Our findings are in agreement with numerous studies showing that TSPAN1 is upregulated in several other cancer types15, 17, 25–28, but are in contrast to a recent publication suggesting that decreased TSPAN1 is linked to prostate cancer progression29. Here, TSPAN1 is linked to prostate carcinoma.